8 completed. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 8 |
Follow Leukemia, B-Cell: new trials by email Literature Review of Leukemia, B-Cell trials Research Report on Leukemia, B-Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma Acalabrutinib capsule - Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma | Phase 4 | Completed | AstraZeneca | 103 | 2021-07-14 | 2024-11-22 |
| A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion Ibrutinib 420 mg, Ibrutinib 560 mg - Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell | Phase 4 | Completed | Johnson & Johnson Private Limited | 75 | 2019-06-26 | 2025-05-25 |
| Antiviral Treatment of Chronic Lymphocytic Leukemia Valganciclovir - Chronic Lymphocytic Leukemia | Phase 4 | Completed | Medical University of Vienna | 20 | 2010-12-01 | 2015-07-21 |
| A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe) bendamustine, chlorambucil, rituximab [MabThera/Rituxan] - Lymphocytic Leukemia, Chronic | Phase 4 | Completed | Hoffmann-La Roche | 357 | 2010-03-01 | 2015-06-25 |
| The Duration of Humoral Immunity and the Memory Cell Function After Vaccination With 7-valent Pneumococcal Conjugate Vaccine in CLL Pneumococcal polysaccharide vaccine (PPV) - Chronic Lymphocytic Leukemia (CLL) | Phase 4 | Completed | Tampere University Hospital | 32 | 2009-06-01 | 2014-02-19 |
| Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL) Ofatumumab - Leukaemia, Lymphocytic, Chronic | Phase 4 | Completed | GlaxoSmithKline | 29 | 2009-01-01 | 2014-05-14 |
| A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia Fludarabine Phosphate (Fludara) - Leukemia, Lymphocytic, Chronic, B-Cell | Phase 4 | Completed | Genzyme, a Sanofi Company | 10 | 2000-11-01 | 2013-12-04 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer anti-thymocyte globulin, filgrastim, cyclophosphamide - Anemia, Graft Versus Host Disease | Phase 4 | Completed | University of Maryland, Baltimore | 45 | 1998-09-01 | 2019-10-17 |
Leukemia, Lymphocytic, Chronic, B-Cell (8) · Lymphoma, Mantle-Cell (3) · Recurrence (2) · Anemia (1) · Blast Crisis (1) · Burkitt Lymphoma (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Graft vs Host Disease (1) · Hodgkin Disease (1) · Leukemia (1) · Leukemia, Basophilic, Acute (1) · Leukemia, Eosinophilic, Acute (1) · Leukemia, Megakaryoblastic, Acute (1) · Leukemia, Myeloid, Accelerated Phase (1)
Chronic Disease (8) · Disease Attributes (8) · Hematologic Diseases (8) · Hemic and Lymphatic Diseases (8) · Immune System Diseases (8) · Immunoproliferative Disorders (8) · Leukemia, Lymphoid (8) · Lymphatic Diseases (8) · Lymphoproliferative Disorders (8) · Neoplasms (8) · Neoplasms by Histologic Type (8) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Leukemia (7)
Antilymphocyte Serum (1) · Bendamustine Hydrochloride (1) · Chlorambucil (1) · Cyclophosphamide (1) · Filgrastim (1) · Pneumococcal Vaccines (1) · Radiotherapy (1) · Rituximab (1) · Thiotepa (1) · Valganciclovir (1) · acalabrutinib (1) · fludarabine phosphate (1) · ibrutinib (1) · ofatumumab (1)
AstraZeneca (1) · Genzyme, a Sanofi Company (1) · GlaxoSmithKline (1) · Hoffmann-La Roche (1) · Johnson & Johnson Private Limited (1) · Medical University of Vienna (1) · Tampere University Hospital (1) · University of Maryland, Baltimore (1)
Finland (2) · India (2) · Sweden (2) · Austria (1) · France (1) · Portugal (1) · Spain (1) · Tunisia (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)
Barry R. Meisenberg, MD (1) · Christoph Steininger, MD (1)
PMID 26377300, PMID 29420116, PMID 42787222
2009 (2)